Phase 4 Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have tested positive for a specific hepatitis B surface marker (HBsAg), negative for another hepatitis B marker (HBeAg), and positive for the antibody related to that second marker
- People who have been on a single antiviral medication for hepatitis B continuously for at least one and a half years
- People whose hepatitis B virus levels have been undetectable in the blood on three separate occasions, each at least 6 months apart, in line with a recognised guideline for stopping treatment
- People who have read, understood, and signed the trial consent form
Who may not be able to join:
- People who have other liver diseases in addition to hepatitis B
- People who are also infected with other hepatitis viruses or HIV
- People who are unwilling to stop their current hepatitis B antiviral medication as part of the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 852-28613777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of HBsAg clearance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.